Surface Oncology Inc. (SURF) NASDAQ
$1.07 - (-)
Market Cap: -
As of 09/07/23 12:00 AM EDT. Market closed.
Surface Oncology Inc. (SURF)
NASDAQ
$1.07
- (-)
Market Cap: -
As of 09/07/23 12:00 AM EDT. Market closed.
Add to Portfolio
surface oncology was created to advance next?generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno?biology. the company’s scientific founders and sab are comprised of world?leading immunologists and cancer researchers, including co?chairs sasha rudensky (memorial sloan kettering) and arlene sharpe ... read more
surface oncology was created to advance next?generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno?biology. the company’s scientific founders and sab are comprised of world?leading immunologists and cancer researchers, including co?chairs sasha rudensky (memorial sloan kettering) and arlene sharpe (harvard/dfci). they are joined on the sab by christopher hunter and john wherry (university of pennsylvania), carla rothlin (yale university), elliott sigal, and john stagg (university of montreal). surface oncology recently completed a $35 million series a financing round with a-list backers. atlas venture, which seeded the company in 2014, led the round, joined by new enterprise associates, fidelity biosciences, lilly ($lly) ventures, amgen ($amgn) ventures, novartis ($nvs) institute for biomedical research, and elliott sigal, the former head of r&d at bristol-myers. for more information, visit ww read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
J. Jeffrey Goater
Full Time Employees
90
CEO Compensation (Base)
$429,000
CEO Compensation (Total)
$4.74M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
J. Jeffrey Goater
Full Time Employees
90
CEO Compensation (Base)
$429,000
CEO Compensation (Total)
$4.74M
Address
50 Hampshire St Fl 8, Massachusetts, Cambridge, 02139-1548.
PRICE CHART FOR SURFACE ONCOLOGY INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.91
Previous Close
$1.07
Days Range
$1.01 - $1.09
52 week range
- - -
Volume
1,510,170
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
60,824,474
Open
$0.91
Previous Close
$1.07
Days Range
$1.01 - $1.09
52 week range
- - -
Volume
1,510,170
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
60,824,474
FINANCIAL STATEMENTS FOR SURFACE ONCOLOGY INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SURFACE ONCOLOGY INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Adams Chandra | Deputy GC | Aug 01, 2023 | Sale | $0.94 | 3,901 | 3,667 | 30,899 | Aug 11, 2023, 08:00 PM |
| FEES JESSICA | Chief Financial Officer | Aug 01, 2023 | Sale | $0.94 | 9,434 | 8,868 | 101,915 | Aug 11, 2023, 08:00 PM |
| ONEILL ALISON | Chief Medical Officer | Aug 01, 2023 | Sale | $0.94 | 7,042 | 6,619 | 56,686 | Aug 11, 2023, 08:00 PM |
| ROSS ROBERT W. | Chief Executive Officer | Aug 01, 2023 | Sale | $0.94 | 16,713 | 15,710 | 83,193 | Aug 11, 2023, 08:00 PM |
| RATH HENRY C. | Chief Business Officer | Aug 03, 2022 | Sale | $1.72 | 5,676 | 9,763 | 32,324 | Aug 05, 2022, 08:01 PM |
| ONEILL ALISON | Chief Medical Officer | Aug 03, 2022 | Sale | $1.72 | 4,463 | 7,676 | 63,728 | Aug 05, 2022, 08:01 PM |
| ROSS ROBERT W. | Chief Executive Officer | Aug 03, 2022 | Sale | $1.72 | 10,594 | 18,222 | 99,906 | Aug 05, 2022, 08:00 PM |
| FEES JESSICA | Chief Financial Officer | Aug 03, 2022 | Sale | $1.72 | 5,980 | 10,286 | 111,349 | Aug 05, 2022, 08:00 PM |
| Palombella Vito J. | Chief Scientific Officer | Aug 03, 2022 | Sale | $1.72 | 4,463 | 7,676 | 87,212 | Aug 05, 2022, 08:00 PM |
| Goater Jeff | Director | Jul 21, 2021 | Sale | $6.10 | 127,778 | 779,446 | 129,222 | Jan 14, 2022, 08:30 PM |
| FEES JESSICA | Chief Financial Officer | Jul 21, 2021 | Sale | $6.10 | 19,854 | 121,109 | 79,329 | Jan 14, 2022, 08:30 PM |
| Palombella Vito J. | Chief Scientific Officer | Jul 21, 2021 | Sale | $6.10 | 26,325 | 160,582 | 53,675 | Jan 14, 2022, 08:30 PM |
| ROSS ROBERT W. | Chief Executive Officer | Jul 21, 2021 | Sale | $6.10 | 33,500 | 204,350 | 54,500 | Jan 14, 2022, 08:30 PM |
| Nogelo Liisa I | Chief Legal Officer | Jul 21, 2021 | Sale | $6.10 | 26,325 | 160,582 | 53,675 | Jan 14, 2022, 08:30 PM |
| ONEILL ALISON | Chief Medical Officer | Jul 21, 2021 | Sale | $6.10 | 14,809 | 90,335 | 30,191 | Jan 14, 2022, 08:30 PM |
| ROSS ROBERT W. | Chief Medical Officer | Feb 16, 2021 | Sale | $11.35 | 1,000 | 11,350 | 88,000 | Feb 18, 2021, 08:00 PM |
| FEES JESSICA | See Remarks | Feb 08, 2021 | Sale | $12.45 | 1,500 | 18,675 | 99,183 | Feb 09, 2021, 08:00 PM |
| Goater Jeff | Chief Executive Officer | Feb 08, 2021 | Option Exercise | $3.18 | 2,500 | 7,950 | 264,500 | Feb 09, 2021, 08:00 PM |
| Goater Jeff | Chief Executive Officer | Feb 08, 2021 | Sale | $12.50 | 2,500 | 31,250 | 262,000 | Feb 09, 2021, 08:00 PM |
| Goater Jeff | Chief Executive Officer | Feb 01, 2021 | Option Exercise | $3.18 | 2,500 | 7,950 | 264,500 | Feb 03, 2021, 08:00 PM |
| Goater Jeff | Chief Executive Officer | Feb 01, 2021 | Sale | $10.69 | 2,500 | 26,718 | 262,000 | Feb 03, 2021, 08:00 PM |
| FEES JESSICA | See Remarks | Feb 01, 2021 | Sale | $11.19 | 1,500 | 16,785 | 100,683 | Feb 03, 2021, 08:00 PM |
| Goater Jeff | Chief Executive Officer | Jan 19, 2021 | Option Exercise | $3.18 | 5,000 | 15,900 | 267,000 | Jan 21, 2021, 08:17 PM |
| Goater Jeff | Chief Executive Officer | Jan 19, 2021 | Sale | $13.00 | 5,000 | 65,000 | 262,000 | Jan 21, 2021, 08:17 PM |
| ROSS ROBERT W. | Chief Medical Officer | Jan 15, 2021 | Sale | $12.25 | 2,000 | 24,500 | 89,000 | Jan 15, 2021, 08:00 PM |
| ROSS ROBERT W. | Chief Medical Officer | Jan 14, 2021 | Sale | $11.95 | 7,000 | 83,650 | 91,000 | Jan 15, 2021, 08:00 PM |
| GRAYZEL DAVID S. | Director | Dec 17, 2020 | Sale | $8.10 | 1,700,000 | 13,770,001 | 2,945,453 | Dec 21, 2020, 03:35 PM |
| Atlas Venture Fund IX, L.P. | 10% Owner | Dec 17, 2020 | Sale | $8.10 | 1,700,000 | 13,770,001 | 2,945,453 | Dec 21, 2020, 03:35 PM |
| GRAYZEL DAVID S. | Director | Dec 17, 2020 | Sale | $18.10 | 1,700,000 | 30,770,001 | 2,945,453 | Dec 21, 2020, 01:32 PM |
| Atlas Venture Fund IX, L.P. | 10% Owner | Dec 17, 2020 | Sale | $18.10 | 1,700,000 | 30,770,001 | 2,945,453 | Dec 21, 2020, 01:32 PM |
| ROSS ROBERT W. | Chief Medical Officer | Dec 15, 2020 | Sale | $10.48 | 1,000 | 10,480 | 98,000 | Dec 17, 2020, 08:00 PM |
| ROSS ROBERT W. | Chief Medical Officer | Dec 11, 2020 | Sale | $10.05 | 1,405 | 14,120 | 99,000 | Dec 15, 2020, 08:00 PM |
| FEES JESSICA | See Remarks | Nov 25, 2020 | Option Exercise | $5.06 | 1,383 | 6,996 | 102,183 | Nov 27, 2020, 08:00 PM |
| ROSS ROBERT W. | Chief Medical Officer | Nov 11, 2020 | Sale | $10.05 | 595 | 5,980 | 100,405 | Nov 13, 2020, 08:00 PM |
| FEES JESSICA | See Remarks | Oct 28, 2020 | Option Exercise | $4.14 | 4,895 | 20,262 | 100,800 | Oct 30, 2020, 08:30 PM |
| ROSS ROBERT W. | Chief Medical Officer | Oct 14, 2020 | Sale | $10.05 | 4,000 | 40,200 | 101,000 | Oct 16, 2020, 08:02 PM |
| EcoR1 Capital, LLC | 10% Owner | Sep 01, 2020 | Sale | $7.14 | 332,780 | 2,376,682 | 4,701,081 | Sep 03, 2020, 04:17 PM |
| New Enterprise Associates 14, L.P. | 10% Owner | May 20, 2020 | Sale | $3.66 | 420,000 | 1,535,562 | 2,892,877 | May 22, 2020, 04:56 PM |
| Dwyer Wendy | Chief Business Officer | Feb 28, 2020 | Option Exercise | $1.70 | 5,000 | 8,500 | 85,000 | Mar 03, 2020, 04:05 PM |
| Goater Jeff | Chief Executive Officer | Feb 05, 2020 | Buy | $3.23 | 5,000 | 16,150 | 262,000 | Feb 07, 2020, 04:05 PM |
| FEES JESSICA | See Remarks | Apr 01, 2019 | Option Exercise | $0.35 | 2,728 | 960 | 50,905 | Apr 02, 2019, 07:00 PM |
| ROSS ROBERT W. | Chief Medical Officer | Jan 04, 2019 | Option Exercise | $4.14 | 25,000 | 103,400 | 25,000 | Jan 08, 2019, 04:05 PM |
| FEES JESSICA | See Remarks | Jan 04, 2019 | Option Exercise | $1.11 | 2,273 | 2,522 | 48,177 | Jan 08, 2019, 04:05 PM |
| Viswanathan Ravi | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 3,312,877 | Apr 23, 2018, 04:48 PM |
| Sonsini Peter W. | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 3,312,877 | Apr 23, 2018, 04:48 PM |
| SANDELL SCOTT D | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 3,312,877 | Apr 23, 2018, 04:47 PM |
| MOTT DAVID M | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 3,312,877 | Apr 23, 2018, 04:47 PM |
| KERINS PATRICK J | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 3,312,877 | Apr 23, 2018, 04:47 PM |
| Florence Anthony A. Jr. | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 3,312,877 | Apr 23, 2018, 04:46 PM |
| BASKETT FOREST | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 3,312,877 | Apr 23, 2018, 04:46 PM |
| BARRIS PETER J | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 3,312,877 | Apr 23, 2018, 04:45 PM |
| BARRETT M JAMES | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 3,312,877 | Apr 23, 2018, 04:45 PM |
| New Enterprise Associates 14, L.P. | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 133,333 | 1,999,995 | 3,312,877 | Apr 23, 2018, 04:45 PM |
| Novartis Institutes for BioMedical Research, Inc. | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 766,666 | 11,499,990 | 3,948,482 | Apr 23, 2018, 04:43 PM |
| Atlas Venture Fund IX, L.P. | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 100,000 | 1,500,000 | 4,645,453 | Apr 23, 2018, 04:18 PM |
| GRAYZEL DAVID S. | Director | Apr 23, 2018 | Buy | $15.00 | 100,000 | 1,500,000 | 4,645,453 | Apr 23, 2018, 04:18 PM |
| LV Management Group, LLC | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 266,000 | 3,990,000 | 3,447,817 | Apr 23, 2018, 04:16 PM |
| Shanafelt Armen | Director | Apr 23, 2018 | Buy | $15.00 | 266,000 | 3,990,000 | 3,447,817 | Apr 23, 2018, 04:16 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Adams Chandra | Deputy GC | 08/01/2023 | 3,667 |
| FEES JESSICA | Chief Financial Officer | 08/01/2023 | 8,868 |
| ONEILL ALISON | Chief Medical Officer | 08/01/2023 | 6,619 |
| ROSS ROBERT W. | Chief Executive Officer | 08/01/2023 | 15,710 |
| RATH HENRY C. | Chief Business Officer | 08/03/2022 | 9,763 |
| ONEILL ALISON | Chief Medical Officer | 08/03/2022 | 7,676 |
| ROSS ROBERT W. | Chief Executive Officer | 08/03/2022 | 18,222 |
| FEES JESSICA | Chief Financial Officer | 08/03/2022 | 10,286 |
| Palombella Vito J. | Chief Scientific Officer | 08/03/2022 | 7,676 |
| Goater Jeff | Director | 07/21/2021 | 779,446 |
| FEES JESSICA | Chief Financial Officer | 07/21/2021 | 121,109 |
| Palombella Vito J. | Chief Scientific Officer | 07/21/2021 | 160,582 |
| ROSS ROBERT W. | Chief Executive Officer | 07/21/2021 | 204,350 |
| Nogelo Liisa I | Chief Legal Officer | 07/21/2021 | 160,582 |
| ONEILL ALISON | Chief Medical Officer | 07/21/2021 | 90,335 |
| ROSS ROBERT W. | Chief Medical Officer | 02/16/2021 | 11,350 |
| FEES JESSICA | See Remarks | 02/08/2021 | 18,675 |
| Goater Jeff | Chief Executive Officer | 02/08/2021 | 7,950 |
| Goater Jeff | Chief Executive Officer | 02/08/2021 | 31,250 |
| Goater Jeff | Chief Executive Officer | 02/01/2021 | 7,950 |
| Goater Jeff | Chief Executive Officer | 02/01/2021 | 26,718 |
| FEES JESSICA | See Remarks | 02/01/2021 | 16,785 |
| Goater Jeff | Chief Executive Officer | 01/19/2021 | 15,900 |
| Goater Jeff | Chief Executive Officer | 01/19/2021 | 65,000 |
| ROSS ROBERT W. | Chief Medical Officer | 01/15/2021 | 24,500 |
| ROSS ROBERT W. | Chief Medical Officer | 01/14/2021 | 83,650 |
| GRAYZEL DAVID S. | Director | 12/17/2020 | 13,770,001 |
| Atlas Venture Fund IX, L.P. | 10% Owner | 12/17/2020 | 13,770,001 |
| GRAYZEL DAVID S. | Director | 12/17/2020 | 30,770,001 |
| Atlas Venture Fund IX, L.P. | 10% Owner | 12/17/2020 | 30,770,001 |
| ROSS ROBERT W. | Chief Medical Officer | 12/15/2020 | 10,480 |
| ROSS ROBERT W. | Chief Medical Officer | 12/11/2020 | 14,120 |
| FEES JESSICA | See Remarks | 11/25/2020 | 6,996 |
| ROSS ROBERT W. | Chief Medical Officer | 11/11/2020 | 5,980 |
| FEES JESSICA | See Remarks | 10/28/2020 | 20,262 |
| ROSS ROBERT W. | Chief Medical Officer | 10/14/2020 | 40,200 |
| EcoR1 Capital, LLC | 10% Owner | 09/01/2020 | 2,376,682 |
| New Enterprise Associates 14, L.P. | 10% Owner | 05/20/2020 | 1,535,562 |
| Dwyer Wendy | Chief Business Officer | 02/28/2020 | 8,500 |
| Goater Jeff | Chief Executive Officer | 02/05/2020 | 16,150 |
| FEES JESSICA | See Remarks | 04/01/2019 | 960 |
| ROSS ROBERT W. | Chief Medical Officer | 01/04/2019 | 103,400 |
| FEES JESSICA | See Remarks | 01/04/2019 | 2,522 |
| Viswanathan Ravi | 10% Owner | 04/23/2018 | 1,999,995 |
| Sonsini Peter W. | 10% Owner | 04/23/2018 | 1,999,995 |
| SANDELL SCOTT D | 10% Owner | 04/23/2018 | 1,999,995 |
| MOTT DAVID M | 10% Owner | 04/23/2018 | 1,999,995 |
| KERINS PATRICK J | 10% Owner | 04/23/2018 | 1,999,995 |
| Florence Anthony A. Jr. | 10% Owner | 04/23/2018 | 1,999,995 |
| BASKETT FOREST | 10% Owner | 04/23/2018 | 1,999,995 |
| BARRIS PETER J | 10% Owner | 04/23/2018 | 1,999,995 |
| BARRETT M JAMES | 10% Owner | 04/23/2018 | 1,999,995 |
| New Enterprise Associates 14, L.P. | 10% Owner | 04/23/2018 | 1,999,995 |
| Novartis Institutes for BioMedical Research, Inc. | 10% Owner | 04/23/2018 | 11,499,990 |
| Atlas Venture Fund IX, L.P. | 10% Owner | 04/23/2018 | 1,500,000 |
| GRAYZEL DAVID S. | Director | 04/23/2018 | 1,500,000 |
| LV Management Group, LLC | 10% Owner | 04/23/2018 | 3,990,000 |
| Shanafelt Armen | Director | 04/23/2018 | 3,990,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR SURFACE ONCOLOGY INC
STOCK BUYBACKS FOR SURFACE ONCOLOGY INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
0.15%
1Q
12/31/2022
0.17%
2Q
09/30/2022
2.82%
3Q
06/30/2022
11.09%
4Q
03/31/2022
21.88%
5Q
12/31/2021
30.74%
6Q
09/30/2021
34.22%
7Q
06/30/2021
39.15%
8Q
03/31/2021
45.89%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SURFACE ONCOLOGY INC
LOADING...